Do podcasts influence health behaviors?

EU reg­u­la­to­ry au­thor­i­ties grant­ed con­di­tion­al ap­proval to Re­gen­eron’s bis­pe­cif­ic an­ti­body odronex­tam­ab for two forms of lym­phoma. It’s Re­gen­eron’s first bis­pe­cif­ic an­ti­body ap­proval in the world

Immune checkpoint inhibitors are at the forefront of treatment options for melanoma, leading to durable disease control and long-term survivors. But as a result, these